← Browse by Condition
Medical Condition
retinoblastoma
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for retinoblastoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — retinoblastoma Clinical Trials
How many clinical trials are currently recruiting for retinoblastoma?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for retinoblastoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for retinoblastoma?
retinoblastoma research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a retinoblastoma clinical trial?
Eligibility criteria for retinoblastoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04425434
Recruiting
Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
Enrollment
3,000 pts
Location
Burkina Faso, Côte d...
Sponsor
French Africa Pediatric Oncolo...
NCT06679634 Phase 2
Recruiting
Retinoblastoma Phase II Expanded Access Clinical Trial
Enrollment
30 pts
Location
United States
Sponsor
Targeted Therapy Technologies,...
NCT06725173
Recruiting
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
Enrollment
100 pts
Location
United States
Sponsor
University of Washington
NCT06367530
Recruiting
Trilateral Retinoblastoma: Incidence and Outcomes
Enrollment
4,351 pts
Location
Netherlands
Sponsor
Amsterdam UMC, location VUmc
NCT05080010 Phase 3
Recruiting
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Enrollment
500 pts
Location
China
Sponsor
Sun Yat-sen University
NCT04959097
Recruiting
Retinoblastoma Patient Clinical Database and Tissue Repository
Enrollment
800 pts
Location
United States, Canad...
Sponsor
Children's Hospital Los Angele...
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Enrollment
1,500 pts
Location
United States
Sponsor
St. Jude Children's Research H...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology